Toshihiko Saeki

2.7k total citations · 2 hit papers
30 papers, 2.4k citations indexed

About

Toshihiko Saeki is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Toshihiko Saeki has authored 30 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Toshihiko Saeki's work include Nitric Oxide and Endothelin Effects (16 papers), Chemokine receptors and signaling (8 papers) and Receptor Mechanisms and Signaling (8 papers). Toshihiko Saeki is often cited by papers focused on Nitric Oxide and Endothelin Effects (16 papers), Chemokine receptors and signaling (8 papers) and Receptor Mechanisms and Signaling (8 papers). Toshihiko Saeki collaborates with scholars based in Japan, United Kingdom and Norway. Toshihiko Saeki's co-authors include Takahiro Fukuroda, Mitsuo Yano, Masaki Ihara, Kazuhito Noguchi, Masaru Nishikibe, Takehiro Fukami, Kiyofumi Ishikawa, Sonoko Tsuchida, Satoshi Ozaki and M. Ihara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Toshihiko Saeki

28 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor

1992 774 citations Masaki Ihara, Kazuhito Noguchi et al. Life Sciences profile →
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

1994 517 citations Kiyofumi Ishikawa, M. Ihara et al. profile →

Peers

Countries citing papers authored by Toshihiko Saeki

Since Specialization

Citations

This map shows the geographic impact of Toshihiko Saeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Saeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Saeki more than expected).

Fields of papers citing papers by Toshihiko Saeki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihiko Saeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Saeki. The network helps show where Toshihiko Saeki may publish in the future.

Co-authorship network of co-authors of Toshihiko Saeki

This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiko Saeki. A scholar is included among the top collaborators of Toshihiko Saeki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiko Saeki. Toshihiko Saeki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemokine CCR3 antagonists 2004 ·Expert Opinion on Therapeutic Patents ·Akira Naya, Toshihiko Saeki	2
2	CCR1 Chemokine Receptor Antagonist 2003 ·Current Pharmaceutical Design ·Toshihiko Saeki, Akira Naya	32
3	Structure–activity relationships of xanthene carboxamides, novel CCR1 receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry ·Akira Naya, Makoto Ishikawa, Kenji Matsuda, Kenji Ohwaki, Toshihiko Saeki, Kazuhito Noguchi, Norikazu Ohtake	56
4	Structure-Activity Relationships of 2-(Benzothiazolylthio)acetamide Class of CCR3 Selective Antagonist 2003 ·Chemical and Pharmaceutical Bulletin ·Akira Naya, Kensuke Kobayashi, Makoto Ishikawa, Kenji Ohwaki, Toshihiko Saeki, Kazuhito Noguchi, Norikazu Ohtake	31
5	Eotaxin induces migration of RBL-2H3 mast cells via a Rac-ERK-dependent pathway 2002 ·Biochemical and Biophysical Research Communications ·Chang-Hoon Woo, (unknown), (unknown), (unknown), Il Yup Chung, Toshihiko Saeki, Jae‐Hong Kim	34
6	Identification of a Potent and Nonpeptidyl CCR3 Antagonist 2001 ·Biochemical and Biophysical Research Communications ·Toshihiko Saeki, Kenji Ohwaki, Akira Naya, Kensuke Kobayashi, Makoto Ishikawa, Norikazu Ohtake, Kazuhito Noguchi	22
7	Endothelin Receptor Antagonists with Various Subtype-Specificity: Their Discovery and Use as Pharmacological Tools 1995 ·European Journal of Medicinal Chemistry ·Kiyofumi Ishikawa, Takehiro Fukami, Toshiaki Mase, (unknown), Takashi Hayama, Kenji Niiyama, Masaki Ihara, Toshihiko Saeki, Satoshi Ozaki, Masaru Nishikibe, (unknown), Kazuhito Noguchi, Takahiro Fukuroda, Mitsuo Yano	3
8	Structure-Activity Relationships of Cyclic Pentapeptide Endothelin A Receptor Antagonists 1995 ·Journal of Medicinal Chemistry ·Takehiro Fukami, (unknown), Kagari Fujita, Takashi Hayama, Kenji Niiyama, Toshiaki Mase, Shigeru Nakajima, Takahiro Fukuroda, Toshihiko Saeki	29
9	Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Satoshi Ozaki, M. Ihara, Toshihiko Saeki, Tatsuki Fukami, Kiyofumi Ishikawa, M. Yano	15
10	A novel ligand, [125I]BQ-3020, reveals the localization of endothelin ETB receptors 1993 ·European Journal of Pharmacology ·Masahiko Kobayashi, Masaki Ihara, Noriko Sato, Toshihiko Saeki, Satoshi Ozaki, Fumihiko Ikemoto, Mitsuo Yano	14
11	Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1 1992 ·Biochemical and Biophysical Research Communications ·(unknown), Masaki Ihara, Masahiko Kobayashi, Toshihiko Saeki, Kiyofumi Ishikawa, Mitsuo Yano	85
12	A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptors 1992 ·Life Sciences ·Masaki Ihara, Toshihiko Saeki, Takahiro Fukuroda, (unknown), Satoshi Ozaki, (unknown), Mitsuo Yano	96
13	Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor breakdown → 1992 ·Life Sciences ·Masaki Ihara, Kazuhito Noguchi, Toshihiko Saeki, Takahiro Fukuroda, Sonoko Tsuchida, (unknown), Takehiro Fukami, (unknown), Masaru Nishikibe, Mitsuo Yano	774
14	In Vitro Biological Profile of a Highly Potent Novel Endothelin (ET) Antagonist BQ-123 Selective for the ETA Receptor 1992 ·Journal of Cardiovascular Pharmacology ·Masaki Ihara, Kiyofumi Ishikawa, Takahiro Fukuroda, Toshihiko Saeki, Kaoru Funabashi, Takehiro Fukami, Hiroyuki Suda, Mitsuo Yano	102
15	A novel radiologand [[sup 125]I]BQ-3020 selective for endothelin (ET[sub B]) receptors 1992 ·OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) ·Masaki Ihara, Toshihiko Saeki, Takahiro Fukuroda, (unknown), Satoshi Ozaki, Mitsuo Yano, (unknown)	1
16	Suppressive effects of the endothelin receptor (ETA) antagonist BQ-123 on ET-1-induced reduction of lipoprotein lipase activity in 3T3-L1 adipocytes 1992 ·Biochemical Pharmacology ·(unknown), (unknown), Toshihiko Saeki, (unknown), Masaki Ihara, (unknown), Mitsuo Yano	12
17	An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis 1991 ·Biochemical and Biophysical Research Communications ·Masaki Ihara, Takahiro Fukuroda, Toshihiko Saeki, Masaru Nishikibe, KATSUHISA KOJIRI, Hiroyuki Suda, Mitsuo Yano	165
18	Two Endothelin Receptor Subtypes in Porcine Arteries 1991 ·Journal of Cardiovascular Pharmacology ·M. Ihara, Toshihiko Saeki, Kaoru Funabashi, (unknown), M. Yano, Takahiro Fukuroda, Mitsuru Miyaji, M. Nishikibe, Fumihiko Ikemoto	45
19	[Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity 1991 ·Biochemical and Biophysical Research Communications ·Toshihiko Saeki, Masaki Ihara, Takahiro Fukuroda, (unknown), Mitsuo Yano	135
20	Evidence that C4b-binding protein is an acute phase protein 1989 ·Biochemical and Biophysical Research Communications ·Toshihiko Saeki, (unknown), Mamoru Nukatsuka, Yukihiro Kusunoki, Shigeharu Nagasawa	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact